Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel
for
Non-Hodgkin Lymphoma, Large B-cell Lymphoma
Location: Palo Alto CA
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT05794958
Phase1, Recruiting
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
for
Acute Leukemia, Acute Myeloid Leukemia,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0 - 25
Code: NCT03810196
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Boston MA, New Haven CT, New York NY, Paramus NJ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06742996
Phase3, Recruiting
CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
for
Hematologic Malignancy, ALL, Childhood, AML, Childhood,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 21
Code: NCT06326463
Phase1, Recruiting
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
for
Leukemia, Lymphoma, Multiple Myeloma,
Location: Omaha NE
Sponsor: University of Nebraska
Sex: All
Age: 19+
Code: NCT04898790
Recruiting
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
for
Relapsed and/or Refractory B-cell Lymphoma
Location: New York NY, Hackensack NJ, Montreal, Norfolk VA,
Sponsor: Kite, A Gilead Company
Sex: All
Age: 18+
Code: NCT04989803
Phase1, Phase2, Recruiting
CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
for
Diffuse Large B Cell Lymphoma
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18 - 70+
Code: NCT06687772
Phase2, Recruiting
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
for
Non Hodgkin Lymphoma, Richter Transformation, Multiple Myeloma,
Location: Boston MA, Chapel Hill NC, Columbus OH, Cincinnati OH,
Sponsor: Newave Pharmaceutical Inc
Sex: All
Age: 13+
Code: NCT04771572
Phase1, Recruiting
Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL
for
Mantle Cell Lymphoma
Location: Miami FL, Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute